RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Icagen, Inc. (NASDAQ: ICGN) today announced that it has regained compliance with the Nasdaq Global Market listing requirements. On January 17, 2007, the Company received notification from the Nasdaq Listing Qualifications Department that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Marketplace Rule 4450(a)(5) after maintaining a closing bid price equal to or in excess of $1.00 for a minimum of ten consecutive days and that the Company’s non-compliance with the listing requirement announced on October 30, 2006, has been rectified.
